| (Values in U.S. Thousands) | Mar, 2026 | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 |
| Sales | 1,970 | 2,230 | 2,310 | 2,400 | 2,280 |
| Sales Growth | -11.66% | -3.46% | -3.75% | +5.26% | -2.98% |
| Net Income | 680 | -3,370 | -4,890 | -2,670 | -1,850 |
| Net Income Growth | +120.18% | +31.08% | -83.15% | -44.32% | -33.09% |
Aspira Women's Health Inc (AWHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aspira Women's Health Inc. engaged in the discovery, development and commercialization of testing options and bio-analytical solutions for women's health. Aspira Women's Health Inc., formerly known as Vermillion Inc., is based in AUSTIN, Texas.
Fiscal Year End Date: 12/31